New York Mets infielder Robinson Cano could be a fit for the Colorado Rockies … at the right price
As we mentioned earlier, this trade by the New York Mets for Robinson Cano is not one of their best trades in recent years. They assumed nearly all of Cano’s contract from the Seattle Mariners and if they want to get rid of their infield logjam, they could trade to the Colorado Rockies … if they take on most of the remainder of the contract.
Cano, 39, signed a ten-year deal with Seattle that started in the 2014 season. He was great in his first season in Seattle (142 OPS+ in 157 games and he came in 5th in AL MVP voting) but since then, he has been a shell of his former self.
His problem in recent years has been steroids. In what ended up being his final season in Seattle (2018), Cano was popped for PED use and specifically, the use of Furosemide, which is best known as Lasix, which is a diuretic. He served 80 games for that.
In 2021, he was popped for steroids again. This time, he was using Stanozolol, which is used to treat hereditary angioedema. Since it was his second offense, he was suspended for 162 games, or the entire season.
In 2020, he was good as, in 49 games, he had 10 homers and 30 RBI with a slash line of .316/.352/.544. That amounted to an OPS+ of 143, which was his best since 2013, which was his final season with the Yankees.
Can Cano replicate that or something close to that? Can he stay off PEDs? Those are two big questions but the biggest one, if the Mets want to trade him, is how much of his salary are they willing to pay?
He is owed $24 million in each of the next two seasons. Seattle is paying for $3.75 million of it in each season. To get a better return from the Rockies, the Mets would have to cover most of the contract.
Cano isn’t very versatile either as he plays second (and the Rockies do need an infielder) and he has played a handful of games at first and two games at third back in 2018 but if the price is right, he could be a good bat for the Rockies.